LA
Standard BioTools Inc.
LAB · NASDAQ
$0.77 +4.75% (+$0.03)
1M +18.43%
Market Cap $301.3M
P/E Ratio -
Div. Yield -
ROE 18.16%
Piotroski F-Score Weak
3/9Valuation
75 /100
Cheap P/S 3.56x
P/B 0.56x
P/E N/A
Growth
0 /100
Declining Rev. growth 4.49%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 49.14%
Net margin 103.29%
FCF margin 97.62%
Quality
2 /100
Poor ROIC 8.25%
ROE 18.16%
Asset turnover 0.13x
Debt
69 /100
Low Debt/Equity 0.05x
Current ratio 9.10x
Int. coverage -6,591.47x
Stability
42 /100
Moderate Beta 1.37x
Rev. volatility 57.57%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o LAB
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Michael Egholm
Employees
387
Headquarters
Boston
Nadchodzące wydarzenia
03 LIS
Earnings
Upcoming earnings report